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Abstract: Bacterial vaginosis (BV) is the most frequent vaginal infection worldwide. It is caused by 
the overgrowth of anaerobic vaginal pathogens such as Gardnerella spp. BV has been associated with 
the occurrence of dense multispecies biofilms on the vaginal mucosa. Treatment of biofilm-associ-
ated infections such as BV is challenging. In this study, we have tested the role of a quaternary 
ammonium compound, dequalinium chloride (DQC), in the eradication of Gardnerella spp. biofilms. 
The effects of the test substance on the biomass and the metabolic activity of the biofilm of Gard-
nerella spp. were assessed in vitro using a microtiter plate assay. In addition, the effect of DQC on 
the Gardnerella spp. biofilm was further assessed by using scanning electron microscopy and confo-
cal laser scanning microscopy. The results showed that DQC was particularly effective in the de-
struction of BV-associated Gardnerella spp. biotypes, impacting both their biomass and metabolic 
activity. In addition, the disruption of biofilm architecture was evident and was probably caused 
by multiple mechanisms of action. We conclude that DQC is an antibiofilm agent and is able to 
efficiently destroy Gardnerella spp. BV-associated biofilms. Therefore, it is a valid option for BV ther-
apy and has the potential to prevent BV recurrences. 
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1. Introduction 
Biofilms are complex arrays of microorganism cells, assembled by superficial pro-
teins and exopolysaccharides [1]. Due to the structure of biofilms, the efficacy of antimi-
crobial compounds against biofilms is generally reduced. A wide array of microbial path-
ogens has been known to form biofilms on mucosa [2] and abiotic structures [3], prevent-
ing effective treatment of infections. Consequently, there has been increasing interest in 
research on new compounds with antibiofilm activity [4]. 
Gardnerella spp. and other anaerobes are vaginal pathogens that have been associated 
with the onset of bacterial vaginosis (BV) [5,6]. Recently, it has been suggested that several 
species of the genus Gardnerella can be involved in this vaginal infection [5]. BV is the most 
common vaginal infection, impacting women’s sexual health and quality of life world-
wide. It is characterized by an exaggerated vaginal discharge, often accompanied by a 
characteristic strong odor [7]. Previous studies have established that Gardnerella spp. iso-
lated from either BV or non-BV/asymptomatic cases are phenotypically different [8]. 
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These have been extensively characterized before; specifically, BV-associated Gardnerella 
spp. have been shown to produce biofilm [8] and have an increased expression of other 
virulence factors, leading, for example, to higher cytotoxicity against epithelial cells [5]. 
The treatment of BV is still challenging, particularly because of the need to eradicate bio-
films [6]. Currently, the most commonly prescribed drugs are metronidazole and 
clindamycin [9]. However, difficulties occur when using these drugs, namely the emer-
gence of resistance to treatment [10] and the inability to eradicate vaginal biofilms [10], 
which often lead to treatment failure and BV recurrences. This resistance to treatment can 
be further complicated by the complex vaginal microbiota, which contains multiple spe-
cies. Treatment with antibiotics causes a shift in the composition of the vaginal microbi-
ome, leading to the emergence of antibiotic-resistant pathogens [11]. 
Dequalinium chloride (DQC) is a quaternary ammonium salt with antimicrobial ac-
tivity that has been mostly used as an antiseptic in the clinical context [12]. DQC also has 
some anti-inflammatory properties [13]. It has been previously demonstrated that the 
compound is active against a wide range of vaginal pathogens, including planktonic cells 
of Gardnerella spp. [13,14]. In addition, because DQC has been described to show multiple 
modes of action against bacteria (disruption of cell permeability and enzymatic inactiva-
tion) [13], the risk for emergence of resistance is considered lower. Likewise, the domi-
nance of the microbiome by resistant bacteria should be a rare event. Furthermore, toxi-
cology assessment studies have revealed that systemic absorption of DQC is negligible 
[15], supporting its safety in clinical use, even during pregnancy. 
Recently, DQC has been demonstrated as a successful treatment of various clinical 
cases of BV [16]. This study aims to add to the knowledge on the efficacy of DQC in the 
treatment of BV, with a particular focus on its role in the eradication of Gardnerella spp. 
biofilms. 
2. Methods 
2.1. Bacterial Strains and Growth Conditions 
Five Gardnerella spp. strains previously obtained in a different study from several 
women’s vaginal tracts were included [8]. Due to their virulent characteristics, the strains 
were previously classified as BV (Gardnerella vaginalis, UM137; Gardnerella spp. UM241) 
and non-BV (Gardnerella vaginalis, UM085; Gardnerella spp. UM131; Gardnerella spp. 
UM246) strains [8,17]. The strains were subcultured twice in Colombia Blood Agar (bio-
Mérieux, Marcy L’Étoile, France) before all experiments were conducted (total incubation 
time of 48 h at 37 °C with 10% CO2). 
2.2. Test Substances 
Dequalinium chloride (DQC) was prepared by dispersing a tablet of the compound 
as it is commercialized (Fluomizin, Medinova, Zürich, Switzerland) in ultrapure water at 
1024 µg/mL. The concentration of the compound used for the experiments was based on 
the minimum inhibitory concentrations previously determined (2–512 µg/mL) [13,14]. 
Clindamycin (IV solution, Labesfal, Santiago de Besteiros, Portugal) was diluted with ul-
trapure water at 150 mg/mL. 
2.3. Culture Conditions for Gardnerella spp. Biofilm Formation 
Two different culture media were used: (1) Supplemented Brain Heart Infusion (BHI) 
medium: BHI medium (VWR, Avantor, PA, USA), 2% (w/v) gelatin (Sigma-Aldrich, Ham-
burg, Germany), 1% (w/v) yeast extract (VWR, Avantor, PA, USA), and 0.1% (w/v) soluble 
starch (Merck, Gernsheim, Germany); (2) New York City III (NYCIII) medium: 0.4% (w/v) 
HEPES buffer (Merck, Gernsheim, Germany), 1.5% (w/v) proteose peptone (VWR, Avan-
tor, PA, USA), 0.5% (w/v) sodium chloride (VWR, Avantor, PA, USA), 0.5% (w/v) glucose 
(VWR, Avantor, PA, USA), 2.5% (w/v) yeast extract (VWR, Avantor, PA, USA), and 10% 
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(v/v) fetal bovine serum (FBS) (Sigma-Aldrich, Hamburg, Germany). The incubation con-
ditions used were as follows: 24 h, 10% CO2, and 37 °C (Binder GmbH, Tuttlingen, Ger-
many). 
2.4. Evaluation of Gardnerella spp. Biofilm Metabolic Activity (MTT) and Biomass (CV) 
A pre-inoculum was performed by growing the strains in NYCIII (incubation for 24 
h at 37 ℃ with 10% CO2). The cellular concentration of the pre-inoculum was adjusted to 
1 × 108 CFU/mL, and the pre-inoculum deposited in flat-bottomed untreated plastic 96-
well plates (in duplicate—two wells per strain/condition). The incubation conditions of 
the plates to allow biofilm formation were 48 h, 10% CO2, and 37 ℃ (Binder GmbH, Ger-
many). Following this incubation, the biofilms were washed three times with sterile PBS 
(phosphate buffered saline) 1× (Sigma-Aldrich, Germany). Afterward, the test substance 
(dequalinium chloride or clindamycin) was applied. Seven symmetric concentrations 
(half-log intervals: 0.26, 0.81, 2.57, 8.11, 25.64, 81.01, and 256 µg/mL) were tested in tripli-
cate including a positive control (that consisted in culture medium only). The incubation 
proceeded for 24 h at 37 °C with 10% CO2. Afterward, the biofilms were washed three 
times with sterile PBS 1× in order to remove traces of the test substances. The quantifica-
tion of the biofilm biomass was performed by fixing the biofilms with methanol (VWR, 
Avantor, USA) for 30 min at room temperature and staining the biomass with crystal vi-
olet (0.01%, w/v) for 30 min at room temperature [18]. Absorbance was read at 630 nm 
(BioRad, Hercules, CA, USA). The metabolic activity of the biofilm was determined by 
incubating the biofilm with culture media supplemented with 1 mg/mL MTT (Sigma-Al-
drich, Germany) for 4 h in 10% CO2 at 37 °C. The resulting formazan crystals were resus-
pended with DMSO (dimethyl sulfoxide) (Sigma-Aldrich, Germany) [18]. Absorbance 
was read at 490 nm (BioRad, USA). The positive control was normalized at 100% bio-
mass/cell viability, and the absorbance values obtained in each assay were normalized 
considering the absorbance values obtained for the positive control. 
2.5. Visualization of the Effect of Dequalinium Chloride Against Formed Gardnerella spp. 
Biofilms 
Biofilms were formed as specified above in a glass coverslip. After the treatment with 
the test substance on a glass coverslip, the biofilm was fixed overnight with 3% (v/v) glu-
taraldehyde (VWR, Avantor, USA) solution in PBS at 4 ℃. Post-fixation of the biofilm was 
done by a 2% (v/v) osmium tetroxide solution (Sigma-Aldrich, Germany) for 1 h at room 
temperature. After each fixation, bacterial cells were washed twice with PBS and dehy-
drated with ethanol (VWR, Avantor, USA) 25%, 50%, 75%, and 100% for 15 min each. In 
addition, the samples were dried overnight using a freeze-drying process (BioGene ly-
ophilizer freeze dryer, BioGene Biotechnologies, Ghaziabad, India). Each sample was 
mounted on double-sided tape glued to an aluminum supporter, and the samples were 
gold-covered using an Ion Coater (Quorum model Q 150R ES, Quorum Technologies, 
United Kingdom). Finally, the preparations were observed using a VP SEM Hitachi S-
3400N (Hitachi Instruments, Inc., San Jose, CA, USA) scanning electron microscope 
(SEM). 
2.6. Study of the Ability of DQC to Penetrate Biofilms of Gardnerella spp. 
To study the ability of DQC to penetrate Gardnerella spp. biofilms, the compound was 
stained with fluorescein isothiocyanate (FITC). Biofilms were formed as above. After the 
incubation period, the biofilms were washed and treated with the test substance stained 
with FITC or with the substance alone. Staining with the DQC–FITC complex was per-
formed by adding a solution of 1 mg/mL of DQC to a solution of 2 mg/mL of FITC in 
ultrapure water. The mixture was allowed to mix at pH 3 and was further neutralized at 
pH 6. The DQC–FITC complex formed was found to be insoluble and therefore was ly-
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ophilized overnight using a freeze-drying process (BioGene lyophilizer freeze dryer, Bio-
Gene Biotechnologies, India). The complex was then resuspended at 256 µg/mL in NYCIII 
culture media with 1% DMSO (Sigma-Aldrich, Germany), and the resulting mixture was 
used to treat preformed biofilms. The biofilms were treated and washed as described 
above. After the washes, 10 µg/mL propidium iodide (Sigma-Aldrich, Germany) and 5 
mM SYTO40 (Sigma-Aldrich, Germany) were added sequentially. Images were obtained 
in a confocal laser scanning microscope (Zeiss LSM 710, Aalen, Germany). A control was 
performed by killing the biofilm cells with 70% ethanol (VWR, Avantor, USA) for 30 min. 
2.7. Analysis of Results 
The results presented represent at least two independent experiments and are ex-
pressed as the mean and the respective standard deviation. The distribution of the con-
centrations obtained for 50% of the destruction of the biofilm biomass (Biomass EC50), as 
well as the concentrations obtained for 50% of the metabolic activity (Metabolic EC50), for 
the strains from each clinical group (BV vs. non-BV) were analyzed for their statistical 
significance using an unpaired Student’s t-test. A paired Student’s t-test was used to ana-
lyze each pair of results (clindamycin vs. DQC) for each strain at each concentration tested. 
Statistically significant results were considered when p < 0.05. 
3. Results and Discussion 
3.1. Comparison of the Gardnerella spp. Ability to form Biofilms Using Two Culture Media 
Culture conditions strongly influence in vitro formation of Gardnerella spp. biofilms 
[19]. Therefore, two different culture conditions were tested in order to choose the condi-
tions that provided the most robust biofilm in order to assess the effect of DQC on its 
structure. Our results revealed that both culture media can sustain Gardnerella spp. biofilm 
growth (Figure 1). In addition, the biofilm obtained using NYCIII medium exhibited an 
absorbance value that was 4 times higher than the one obtained using BHI medium. These 
results demonstrate that NYCIII medium provides a higher number of cells in biofilms, 
which is indicative of a potentially higher Gardnerella spp. growth rate and, consequently, 
a more consistent biofilm. In fact, the in vitro capacity of Gardnerella spp. isolates to pro-
duce biofilms is variable and highly dependent on culture media, as previously described 
[8]. Therefore, for this study, we selected the NYCIII as the culture medium to produce 
biofilms to obtain the most robust structure and thus the worst-case scenario for testing 
the antibiofilm effect of DQC. 




Figure 1. Comparison of the optical density of the biofilms of Gardnerella spp. strains using two different culture condi-
tions. (A). Absorbance of biofilm and planktonic cells on BHI culture medium. (B). Absorbance of biofilm and planktonic 
cells on NYCIII culture medium. (C). Absorbance of biofilm and planktonic cells on BHI culture medium, after the washes 
with PBS 1x. (D). Absorbance of biofilm and planktonic cells on NYCIII culture medium, after the washes with PBS 1×.  
CV: crystal violet (indicative of biofilm biomass; absorbance was read at 630 nm); MTT: conversion of the tetrazolium dye 
MTT to formazan crystals (indicative of metabolic activity; absorbance was read at 490 nm). The results shown represent 
the mean of at least two different independent assays. The respective standard deviation is also shown. 
3.2. Comparison of Antibiofilm Activity of DQC and Clindamycin Against Gardnerella spp. 
The results regarding the effect of DQC on Gardnerella spp. biofilm revealed that the 
substance is particularly effective against the biofilm of BV-associated Gardnerella spp. 
strains (Figure 2) and is able to reduce the metabolism and/or the biomass of these strains 
by at least 50% (efficient concentration, EC50) at a concentration of 8.11 µg/mL (Table 1) 
and by 80% at a concentration of 25.64 µg/mL. The results were similar to the ones pre-
sented by clindamycin: the EC50 of clindamycin was also 8.11 µg/mL. Statistical analysis 
considering the entire dataset revealed that the effect of DQC in the biofilm biomass re-
duction was stronger (p < 0.05) than that of clindamycin. Clindamycin had a stronger effect 
on the reduction of metabolic activity (p < 0.05). 
The non-BV Gardnerella spp. strains showed higher biomass and metabolic EC50; 
nonetheless, DQC was still effective against these, particularly in the reduction of meta-
bolic activity (Table 1). The differences regarding the Biomass EC50 and Metabolic EC50 
between BV and non-BV strains were statistically significant (p < 0.05). These differences 
may be related to the strains’ genotypes. 
The prevalence of some Gardnerella spp. genotypes in BV clinical cases has been pre-
viously reported, along with differences in virulence potential. Specifically, it was previ-
ously shown that BV-associated Gardnerella spp. have (i) a higher cytotoxicity, (ii) a greater 
ability to adhere to HeLa cells, and (iii) a greater ability to displace pre-adhered Lactoba-
cillus crispatus. Since the effects of the compounds were different depending on the phe-
notype and/or disease status of the patients from whom the strains were collected, those 
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differences at the strain level might be related to the enhanced virulence capacity of the 
strains, which could explain their different responses to the compounds[8]. 
Table 1. Effective concentrations of dequalinium chloride in the destruction of bacterial vaginosis (BV) and non-BV asso-
ciated Gardnerella spp. biofilms. 
Strain BV Status Biomass EC50 Metabolic EC50 
085 Non-BV >256 µg/mL 81.01 µg/mL 
131 Non-BV >256 µg/mL 81.01 µg/mL 
246 Non-BV >256 µg/mL 81.01 µg/mL 
137 BV 2.57 µg/mL 2.57 µg/mL 
241 BV 8.11 µg/mL 8.11 µg/mL 
While clindamycin acts by inhibiting protein synthesis [20], quaternary ammonium 
salts, such as DQC, have been described to perturb microorganisms’ cytoplasmatic mem-
brane, although multiple mechanisms of action have been described and are expected for 
this molecule (loss of enzymatic activity, for instance) [12]. At lower concentrations (<8.11 
µg/mL), metabolic activity was increased, especially in the assays with DQC but also for 
some strains exposed to clindamycin. The overall increased metabolic activity at low con-
centrations of the compounds might be a stress-related mechanism employed by the bac-
teria. 
 
Figure 2. Effect of test substance (dequalinium chloride) and clindamycin on BV and non-BV Gardnerella spp. biofilms.  
(A). Metabolic activity (%) of Gardnerella spp. biofilms after treatment with clindamycin. (B). Metabolic activity (%) of 
Gardnerella spp. biofilms after treatment with dequalinium chloride. (C). Biofilm biomass (%) of Gardnerella spp. biofilms 
after treatment with clindamycin. (D). Biofilm biomass (%) of Gardnerella spp. biofilms after treatment with dequalinium 
chloride. CV: crystal violet (indicative of biofilm biomass; absorbance was read at 630 nm); MTT: conversion of 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide to formazan crystals (indicative of metabolic activity; absorbance 
was read at 490 nm). Dark gray = non-BV strains; light gray = BV strains. The results shown represent the mean of at least 
two different independent assays. The respective standard deviation is also shown. 
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The isolation of clindamycin-resistant vaginal microorganisms has already been re-
ported [21]; therefore, alternative treatments are required. Our results reveal that 
clindamycin and DQC have the same ability to eradicate Gardnerella spp. biofilms in vitro. 
These results were expected, since the activity of clindamycin and DQC against BV-asso-
ciated Gardnerella spp. planktonic cells has been reported to be fairly similar (128–256 
µg/mL) [8,14]. Therefore, besides its reported activity against planktonic Gardnerella cells, 
DQC can also impair Gardnerella spp. biofilms with the added advantage of a low emer-
gence of resistance being expected due to its multiple modes of action [12]. Furthermore, 
the range of concentrations that we found to be effective against BV-associated Gardnerella 
spp. biofilms (25.64 µg/mL) is lower than the concentration of the drug that is usually 
prescribed (10 mg/day) as a vaginal pill [13]. Therefore, our results corroborate that treat-
ment with DQC can destroy Gardnerella spp. biofilms in vivo. 
3.3. DQC Interferes with Gardnerella spp. Biofilms by a Nonspecific Mechanism 
The effect on the biofilm of Gardnerella spp. was further visualized using SEM by 
exposing one BV (241) and one non-BV strain (131) to the maximum concentration tested 
(256 µg/mL) and to the concentration able to reduce 50% of the biofilm biomass of strain 
241 (EC50, 8.11 µg/mL, Table 1). These two strains were chosen as representatives of the 
strain collection since they presented a similar biofilm-forming capacity (Figure 1). 
The results showed a visible reduction in biofilm architecture (Figure 3). There is a 
clear loss of cells, evidenced by the large portions of biofilm that detach in comparison 
with the positive control. The detachment causes the formation of holes in the structure 
of biofilms. These results are also evidenced by the loss of biofilm biomass (Figure 2). 
This destruction occurred in both BV- and non-BV-associated biotypes (Figure 2). Since 
the effect of DQC on planktonic cells is already evident [14], by also destroying biofilm 
architecture, the test substance is a promising alternative against BV biofilm treatment. 
 
Figure 3. Visualization of the effect of test substance (dequalinium chloride) on the biomass of BV and non-BV Gardnerella 
spp. biofilms, using scanning electron microscopy (SEM). Positive control: culture media only. The scale indicates 10 µm. 
The ability of the test substance to penetrate Gardnerella spp. biofilms was elucidated 
by staining DQC with a fluorescent compound (FITC) and also by using a fluorophore 
indicative of a primary lesion of the membrane (propidium iodide). Nucleic acids were 
stained with Syto40. The concentration of the test substance stained with FITC used in this 
test was the maximum concentration tested (256 µg/mL). Confocal microscopy further 
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demonstrated the three-dimensional destruction of the biofilm after DQC treatment (Fig-
ure 4 and Supplemental Figure S1). The results show that the DQC–FITC complex is pos-
sibly located primarily at the top of the biofilm layer (Figure 4). This result was expected, 
since the DQC–FITC complex has a greater molecular weight than the test substance 
alone. FITC is widely used to attach a fluorescent label using the amine group. Its structure 
attached to the DQC structure is expected to be complex; furthermore, the active groups 
of the DQC molecule, responsible for its bioactivity, are not probably entirely available. 
In addition, using this methodology, the investigation of the mechanism of action is ham-
pered by the complex architecture of the biofilm. To overcome this limitation, we per-
formed an additional experiment, in which the biofilm was stained after treatment with 
DQC (Supplemental Figure S2). By comparing the results with differential staining using 
different fluorophores, we found that the great majority of the biofilm cells did not incor-
porate propidium iodide, evidencing that the mechanism of action in the destruction of 
biofilms is not probably related to the primary lesion of the cellular membrane. 




Figure 4. Visualization of the test substance (dequalinium chloride, 256 µg/mL) and interaction with Gardnerella spp. bio-
film of non-BV strain 131 (A) and BV strain 241 (B). Green: dequalinium chloride (FITC), blue: nucleic acids (Syto40); red: 
dead cells (propidium iodide, PI). Live: positive control, culture media was used to form biofilms. Dead: 70% ethanol was 
used to kill formed biofilms. Dequalinium chloride: treated biofilms with the dequalinium chloride–FITC complex. Mag-
nification: 40×. 
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Previous studies revealed that DQC affects planktonic cells by diffusion through the 
cell wall and binding itself to the cytoplasmatic membrane [22]. Other mechanisms of ac-
tion include denaturation of proteins [23]. Therefore, lysis of the cytoplasmatic membrane 
might occur, but probably not at the concentration used in our study. We hypothesize that 
at this concentration DQC binds to the cytoplasmatic membrane and probably diffuses to 
the interior of the cells, causing their death and detachment from the biofilm structure. 
Nonetheless, using confocal microscopy, the results obtained with SEM are corroborated 
since three-dimensional impairment of the biofilm was observed. 
4. Conclusions 
Gardnerella spp. strains are able to form biofilm on vaginal tissue, corresponding to 
an important mechanism of virulence. Using in vitro methods, we tested the action of 
DQC on Gardnerella spp. biofilms. Our results revealed that DQC is particularly effective 
against BV-associated Gardnerella spp. biofilms, reducing their biomass and metabolism, 
at concentrations below 256 µg/mL. Scanning electron microscopy (SEM) revealed that 
DQC is also able to destroy the biofilm matrix architecture to some extent. Using fluoro-
phore staining and confocal microscopy, we found that its mechanism of action does not 
seem to be associated with the primary lesion of the cytoplasmatic membrane. 
DQC has already been described as an antimicrobial agent against Gardnerella spp. 
planktonic cells. In this study, we found that in addition to this antimicrobial activity, 
DQC is also active against Gardnerella spp. BV-associated biofilms, thus reducing their 
metabolic activity and to some extent their biomass. Since DQC has demonstrated good 
activity against planktonic cells of Atopobium vaginae [24] and Candida albicans [14], a sim-
ilar effect on combined biofilms, like the ones formed on the vaginal mucosa, could be 
expected. However, scientific data to support this hypothesis are missing. On the other 
hand, the effect on Gardnerella spp. biofilms supports the beneficial properties of DQC in 
the treatment of BV infections, as the molecule is active against Gardnerella spp. biofilms 
and shows a low toxicity level. In contrast to clindamycin, DQC is not expected to induce 
the emergence of resistance in the microorganism cells. 
Supplementary Materials: The following are available online at www.mdpi.com/2076-
0817/10/3/261/s1, Figure S1: 3D representation, depicting the interaction of the test substance 
(dequalinium chloride, 256 µg/mL) with Gardnerella spp. biofilm of BV strain 241. Figure S2: Visu-
alization of Gardnerella spp. biofilm of non-BV strain 131 and BV strain 241 after treatment with the 
test substance (dequalinium chloride, 256 µg/mL).  
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